Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation

Clinical trial NCT03146468 · UNKNOWN

Trial details

NCT number: NCT03146468
Sponsor: Melbourne Health
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Haematological Malignancy

Start date: 2017-05-08
Primary completion: 2022-03-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.